These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18066031)

  • 21. Contamination by hepatitis C in a haemodialysis center: preventive measures.
    Guiserix J
    Nephron; 1996; 72(4):721-2. PubMed ID: 8730457
    [No Abstract]   [Full Text] [Related]  

  • 22. Deal watch: microRNA collaboration to target cardiovascular disease pathways.
    Nat Rev Drug Discov; 2011 Dec; 10(12):890. PubMed ID: 22129979
    [No Abstract]   [Full Text] [Related]  

  • 23. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Learning from HIV: how will drug resistance influence treatment strategies against hepatitis C?
    Durantel D; Zoulim F
    J HIV Ther; 2007 Dec; 12(4):88-91. PubMed ID: 18391894
    [No Abstract]   [Full Text] [Related]  

  • 25. Fragmentary solutions. Astex therapeutics puts the pieces together.
    Wolfson W
    Chem Biol; 2006 Aug; 13(8):799-801. PubMed ID: 16931326
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibitex, Inc: antibody anti-infectives.
    McCarthy AA
    Chem Biol; 2005 Mar; 12(3):257-9. PubMed ID: 15797206
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment and vaccination for hepatitis C: present and future.
    Jawaid A; Khuwaja AK
    J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Competition intensifies around hepatitis C.
    Dorey E
    Nat Biotechnol; 2009 Apr; 27(4):305-6. PubMed ID: 19352356
    [No Abstract]   [Full Text] [Related]  

  • 29. Modifying protein misfolding.
    Jones D
    Nat Rev Drug Discov; 2010 Nov; 9(11):825-7. PubMed ID: 21030987
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis C vaccine: supply and demand.
    Inchauspé G; Honnet G; Bonnefoy JY; Nicosia A; Strickland GT
    Lancet Infect Dis; 2008 Dec; 8(12):739-40. PubMed ID: 19022189
    [No Abstract]   [Full Text] [Related]  

  • 31. Peptides: isolation, production, and use in India.
    Nagaraj R
    Biotechnol J; 2009 Mar; 4(3):329-34. PubMed ID: 19156729
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis C virus. Preface.
    Reddy KR; Kaplan DE
    Clin Liver Dis; 2008 Aug; 12(3):xiii-xiv. PubMed ID: 18625424
    [No Abstract]   [Full Text] [Related]  

  • 33. Approaches for the development of antiviral compounds: the case of hepatitis C virus.
    Schinazi RF; Coats SJ; Bassit LC; Lennerstrand J; Nettles JH; Hurwitz SJ
    Handb Exp Pharmacol; 2009; (189):25-51. PubMed ID: 19048196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Life Sciences Alliance World 2007--a Terrapinn conference.
    Searle B; Shumoogam J
    IDrugs; 2007 Jun; 10(6):370-2. PubMed ID: 17641997
    [No Abstract]   [Full Text] [Related]  

  • 35. Bridging the knowledge gaps in vaccine design.
    Rappuoli R
    Nat Biotechnol; 2007 Dec; 25(12):1361-6. PubMed ID: 18066025
    [No Abstract]   [Full Text] [Related]  

  • 36. The art of self-defence.
    Gewin V
    Nature; 2008 Mar; 452(7186):498-500. PubMed ID: 18444262
    [No Abstract]   [Full Text] [Related]  

  • 37. Trial watch: Opportunities and challenges of the 2016 target landscape.
    Lafferty-Whyte K; Mormeneo D; Del Fresno Marimon M
    Nat Rev Drug Discov; 2017 Jan; 16(1):10-11. PubMed ID: 27980340
    [No Abstract]   [Full Text] [Related]  

  • 38. Possible hepatitis C vaccine.
    AIDS Patient Care STDS; 2007 Sep; 21(9):709. PubMed ID: 17919098
    [No Abstract]   [Full Text] [Related]  

  • 39. Intercell - accelerating innovation.
    Brehme M
    N Biotechnol; 2009 Apr; 25(4):181-4. PubMed ID: 19429533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PSivida corporation.
    Leedman B
    Arzneimittelforschung; 2008; 58(8):425-6. PubMed ID: 18807584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.